Navigation Links
Mylan in Medical News

President Clinton and Mylan Chairman and CEO Robert J. Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug-Resistant HIV in Developing Countries

PITTSBURGH, Aug. 6 /PRNewswire-FirstCall/ -- President Bill Clinton, Mylan Chairman and CEO Robert J. Coury and Matrix Laboratories Founder and Vice Chairman N. Prasad today announced an important agreement to enable better, more affordable treatments for patients on "second-line" antire...

Andrew G. Cuneo Joins Mylan as Vice President of Global Business Development

PITTSBURGH, April 13 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL ) today announced the appointment of former Merrill Lynch investment banker Andrew G. Cuneo as vice president of Global Business Development. Cuneo is responsible for coordinating Mylan's global business development and s...

Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations

PITTSBURGH, July 21 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL ) announced today the appointment of Daniel E. Crookshank as vice president - Investor Relations and as a member of the company's senior leadership team. Reporting to Chief Financial Officer Edward J. Borkowski, Crookshank is...

Mylan Chairman and CEO Robert J. Coury to Ring NASDAQ Stock Market Closing Bell

... PITTSBURGH, July 29 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that its Cha... on the market close of your choice. About mylan Inc. [MYL]: mylan Inc., which provides products to customers in more...

Mylan Announces Enhancements to Executive Management Team

... PITTSBURGH, July 29 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced several key ...he former Merck Generics businesses and in helping mylan to become one of world's largest, quality pharmace.... In addition, Timothy B. Sawyer has joined mylan as senior vice president of Strategic Corporate De...

Mylan Reports That the FDA Determined That All Accusations Were Unfounded

... PITTSBURGH, July 28 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today reported that in addit...ve actions were fully implemented by Mylan. mylan Chairman and CEO Robert J. Coury said: "I want to ...et and our stakeholders take note of this." mylan Inc., which provides products to customers in more...

Mylan Reiterates and Stands Behind Its 48-Year Commitment and Track Record of Quality

... PITTSBURGH, July 26 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) released the following response to a news article pub...ectively. This issue had no impact on the quality of our product." mylan Inc., which provides products to customers in more than 140 countries and t...

Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol

... PITTSBURGH, July 20 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary mylan Pharmaceuticals Inc. has received approval from th...1 for the same strengths, according to IMS Health. mylan has begun to ship this product. Currently...

Mylan Declares Quarterly Preferred Stock Dividend

... PITTSBURGH, July 20 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that in accordance with its 2.139 mil...009, to holders of preferred stock of record as of August 1, 2009. mylan Inc., which provides products to customers in more than 140 countries and t...

Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel(R)

... PITTSBURGH, July 16 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary mylan Pharmaceuticals Inc. has received approval from th...1 for the same strengths, according to IMS Health. mylan has begun to ship this product. Currently...
Mylan in Medical Technology

PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies

...EY LP, PARI's LC Plus nebulizer and PRONEB compressors (Ultra and Ultra II) were used to show that nebulized formoterol fumarate (Perforomist, DEY LP, mylan Inc.) improves pulmonary function. "We are pleased that researchers chose PARI products as the exclusive nebulizer systems for recent studies co...

Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent

...ed lawsuits against each of Mutual Pharmaceutical Company, Inc. ("Mutual"), mylan Pharmaceuticals Inc. ("Mylan") and Impax Laboratories, Inc. ("Impax") in t...ANDAs") to the U.S. Food and Drug Administration ("FDA") by each of Mutual, mylan and Impax requesting approval to manufacture and sell generic versions of D...

Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI

... Inhalation Solution. Dey, L.P. is a subsidiary of mylan Inc. (NYSE: MYL ). About COPD(1) COPD refers ...ce. About Dey, L.P. Dey, L.P., a subsidiary of mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical ... and http://www.perforomist.com . About Mylan mylan Inc., which provides products to customers in more...

NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium

...ta in January 2007 brought established alliances with a number of additional companies, such as Baxter, GlaxoSmithKline (GSK), Merck Generics (part of mylan Inc), UCB and Otsuka, as well as providing revenue streams, complementary products and critical mass. For further information, please visit Vectura's ...

Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients

...y.(4) COPD patients may consider asking their doctor whether nebulized treatment may be right for them. About Dey, L.P. Dey, L.P., a subsidiary of mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for th...

Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone

...d markets Perforomist(TM) Inhalation Solution. Dey, L.P. is a subsidiary of mylan Inc. (NYSE: MYL ). About Perforomist(TM) Inhalation Solution Indicatio...tment may be right for them. About Dey, L.P. Dey, L.P., a subsidiary of mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical company focused on the de...

Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD

... Inhalation Solution. Dey, L.P. is a subsidiary of mylan Inc. (NYSE: MYL ). About Perforomist(TM) Inhalat...tors. About Dey, L.P. Dey, L.P., a subsidiary of mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical ... . Perforomist is a trademark of Dey, L.P. About mylan ...

Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007

...tors. About Dey, L.P. Dey, L.P., a subsidiary of mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical ... . Perforomist is a trademark of Dey, L.P. About mylan mylan Inc. is one of the world's leading quality generic...
Mylan in Biological News

Scientists Propose Sweeping Changes to Naming of Bird Neurosystems to Acknowledge Their True Brainpower

... The Food and Drug Administration (FDA) has granted approval to mylan Technologies, Inc., for the first generic version of Alza Corporation's Duragesic Patch (Fentanyl Transdermal System) used to treat patients suffering...

FDA Clears the Way for Generic Versions of Transdermal Patches to Treat Chronic Pain

... The Food and Drug Administration (FDA) has granted approval to mylan Technologies, Inc., for the first generic version of Alza Corporation's Duragesic Patch (Fentanyl Transdermal System) used to treat patients suffering...
Mylan in Biological Technology

Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, March 20 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ) announces that it has filed a lawsuit in the U.S. District Court of the Southern District of New York against Mylan Inc., Mylan Pharmaceuticals Inc. and Matrix Laboratories...

Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals

FRAZER, Pa. and PHILADELPHIA, Nov. 26 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) and Eurand, Inc. (Nasdaq: EURX ) today announced that they have filed a lawsuit in U.S. District Court in Delaware against Mylan Pharmaceuticals, Inc. and its subsidiary, Mylan, Inc., and Barr Pharma...

Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, February 9 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ), announces that it has received Paragraph IV Notice letters from Barr Laboratories, Inc. ("Barr) and Mylan, Inc. ("Mylan) dated 2 and 4 February 2009 respectively, advisi...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

... PITTSBURGH, July 30 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced its financia... yet another successful quarter on many fronts for mylan as, across the board, we delivered another quarter...lproex Sodium Extended-release (Divalproex), which mylan launched in the first quarter of 2009. ...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...edical Enters into Agreement with BrachySciences II-78 Signet Enters into Agreement with AsymmetRx to Distribute 'Prostate-63' Tests II-79 mylan Pharmaceuticals Obtains FDA Approval for Finasteride's ANDA II-79 Aeterna Zentaris Enters into Agreement with Nippon Kayaku II-79 Progenics Ph...

Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)

... PITTSBURGH, July 7 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary mylan Pharmaceuticals Inc. has received approval from th...31 for the same strength, according to IMS Health. mylan has begun to ship this product. Currently,...

Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market

... PITTSBURGH, June 29 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that it has ... the global marketplace. Through this partnership, mylan and Biocon bring together highly complementary cap...harmaceutical industry, and through this alliance, mylan and Biocon have covered all four corners of what a...

Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period

...ing period of exclusivity PITTSBURGH, June 3 /PRNewswire-FirstCall/ -- mylan Inc.'s (Nasdaq: MYL ) Chief Operating Officer Heather Bresch today testif...ittee hearing can be found at www.mylan.com/breschtestimony060309 . mylan Inc., which provides products to customers in more than 140 countries and t...

Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)

... PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- mylan Inc. (Nasdaq: MYL ) today announced that it has ... for asthma and allergy treatment. Currently, mylan has 117 ANDAs pending FDA approval representing $8... annual brand sales, according to IMS Health. mylan Inc., which provides products to customers in more...

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder

...PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of mylan Inc. (Nasdaq: MYL ), today announced that it has...year agreement with Bristol-Myers. Manufactured by mylan subsidiary mylan Technologies Inc. (MTI), EMSAM is a registered tra...
Other Tags
(Date:10/22/2014)... (PRWEB) October 22, 2014 On Saturday, October ... its fourth annual family health and fitness fair ¡Vive tu ... physical activity and good nutrition for better health and wellness ... which is free and open to the public, will be ... Brownsville, from 9:00 am to 1:00 pm. , “¡Vive ...
(Date:10/22/2014)... Springfield, Va. (PRWEB) October 22, 2014 For ... way to make money; it’s an extension of her life’s ... her latest venture as the owner of FirstLight HomeCare, make ... , “It’s important to me that my work makes a ... always harbored an entrepreneurial spirit, so after much research, I ...
(Date:10/22/2014)... RESTON, Va. (PRWEB) October 22, 2014 ... Healthcare Innovation , which is dedicated to distribute ... efficiency of healthcare delivery worldwide announced the development ... in which patients expect when receiving healthcare. These ... definition for patient-centered care: “providing care that is ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Best Cheap ... in the world. The site has recently announced that ... hosting supplier for people from around the world. , ... in operation today and is providing various kinds of ... the company insists on offering excellent customer service and ...
(Date:10/22/2014)... 22, 2014 Lintelus, Inc., an event ... President of Sales, will be speaking on the subject ... Expo on October 28, at the Holiday Inn in ... booth as well as a Tech Demo at 12:45pm, ... create a more engaging event experience. , The Annual ...
Breaking Medicine News(10 mins):Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2
(Date:10/19/2014)... electricity access in India over the last 30 ... carbon emissions growth during that time, according to ... Nature Climate Change ., "Energy access is fundamental ... of life, including education, communication, and health," says ... , While increased energy access is widely agreed ...
(Date:10/18/2014)... a group of 2,000 patients referred for evaluation ... potential molecular diagnosis for 25 percent, including detection ... new mutations contributing to disease, according to a ... is being released to coincide with the American ... sequencing analyzes the exons or coding regions of ...
(Date:10/17/2014)... – Accurate knowledge regarding Ebola is critical and pertinent ... of hazardous global outbreak and epidemic. The Journal, ... a special issue, Ebola Virus and Public Health, to ... knowledge in this critical societal moment. , On ... Ebola for Clinicians . The primer was prepared by ...
Breaking Biology News(10 mins):Improved electricity access has little impact on climate change 2Whole-exome sequencing shows potential as diagnostic tool 2
Other Contents